Literature DB >> 23292170

Marked decline in beta cell function during pregnancy leads to the development of glucose intolerance in Japanese women.

Yoshifumi Saisho1, Kei Miyakoshi, Satoru Ikenoue, Yoshifumi Kasuga, Tadashi Matsumoto, Kazuhiro Minegishi, Yasunori Yoshimura, Hiroshi Itoh.   

Abstract

The aim of this study is to investigate glucose metabolism longitudinally during pregnancy to explore mechanisms underlying gestational diabetes mellitus (GDM). We reviewed a total of 62 pregnant Japanese women who underwent a 75g oral glucose tolerance test (OGTT) twice during pregnancy (median: early, 13; late, 28 weeks' gestation) because of positive GDM screening. All showed normal OGTT results in early pregnancy. Based on late OGTT, 15 had GDM (late-onset GDM) and 47 normal glucose tolerance (NGT). In early pregnancy, there were no significant differences in insulin sensitivity (insulin sensitivity index derived from OGTT [IS(OGTT)] and homeostasis model assessment for insulin resistance [HOMA-IR]) and insulin secretion (a ratio of the total area-under-the-insulin-curve to the total area-under-the-glucose-curve [AUC(ins/glu)] and insulinogenic index [IGI]) between the NGT and late-onset GDM groups. In each group, insulin sensitivity significantly decreased from early to late pregnancy, most in the late-onset GDM group (each p < 0.05). The insulin secretion showed no significant changes with advancing pregnancy in both of the groups, although late-onset GDM showed significantly lower IGI compared with NGT in late OGTT (p < 0.05). When assessed beta cell function by OGTT-derived disposition index (i.e. Insulin Secretion-Sensitivity Index-2 and IGI/fasting insulin), the indices significantly decreased from early to late pregnancy in the both groups (each p < 0.05). Women with late-onset GDM showed significantly lower indices compared with NGT (each p < 0.05). The failure of beta cell to compensate for decreased insulin sensitivity could contribute to the development of the late-onset GDM.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23292170

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  6 in total

1.  Assessment of predictors of insulin therapy in patients with gestational diabetes diagnosed according to the IADPSG criteria.

Authors:  Keiko Yanagisawa; Mitsue Muraoka; Koichiro Takagi; Yasuhiko Ichimura; Misa Kambara; Asako Sato; Hiroshi Sakura; Yasuko Uchigata
Journal:  Diabetol Int       Date:  2016-05-04

2.  Gestational diabetes mellitus and impaired glucose tolerance pregnant women.

Authors:  Jinhua Wei; Jianbo Gao; Jinluo Cheng
Journal:  Pak J Med Sci       Date:  2014 Nov-Dec       Impact factor: 1.088

3.  Insulin secretory defect may be the major determinant of GDM in lean mothers.

Authors:  M Fakhrul-Alam; M Rakibul-Hasan; M Farid-Uddin; M A Hasanat
Journal:  J Clin Transl Endocrinol       Date:  2020-04-17

4.  Insulin resistance as estimated by the homeostatic method at diagnosis of gestational diabetes: estimation of disease severity and therapeutic needs in a population-based study.

Authors:  Alina Sokup; Barbara Ruszkowska-Ciastek; Krzysztof Góralczyk; Małgorzata Walentowicz; Marek Szymański; Danuta Rość
Journal:  BMC Endocr Disord       Date:  2013-07-02       Impact factor: 2.763

5.  β-Cell death is decreased in women with gestational diabetes mellitus.

Authors:  Lauren A Kenna; John A Olsen; Michael G Spelios; Michael S Radin; Eitan M Akirav
Journal:  Diabetol Metab Syndr       Date:  2016-08-24       Impact factor: 3.320

6.  Glycaemic Variability and Risk Factors of Pregnant Women with and without Gestational Diabetes Mellitus Measured by Continuous Glucose Monitoring.

Authors:  Martina Gáborová; Viera Doničová; Ivana Bačová; Mária Pallayová; Martin Bona; Igor Peregrim; Soňa Grešová; Judita Štimmelová; Barbora Dzugasová; Lenka Šalamonová Blichová; Viliam Donič
Journal:  Int J Environ Res Public Health       Date:  2021-03-25       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.